Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nurse's question could spare patients painful, unneeded IVs

NCT ID NCT07584590

Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a nurse asking a doctor why they are ordering an IV line can reduce unnecessary placements. About 1,680 emergency department patients will take part. The goal is to lower patient pain, infection risk, and costs by avoiding IVs that aren't needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse questioning intervention
What this could lead to
If it works, this could reduce unnecessary IV placements, saving patients pain and lowering infection risks and costs.
What could go wrong
This is an early-stage observational study, not a treatment trial. The intervention is simple questioning, so the impact may be small or hard to measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,680 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients assigned a triage score of 3A, 3B, or 4 according to the French triage scale, or 3 or 4 according to the CIMU triage scale, by the triage nurse * Patients with a blood draw order involving the placement of an occluded catheter * Age 18 years or older * Patients who have read and understood the information sheet * Patients who have given their verbal consent to participate in the study * Patients enrolled in a social security program Exclusion Criteria: * Patients admitted to the emergency department with a pre-existing intravenous line * Patients treated by the Mobile Emergency and Resuscitation Unit outside the hospital * Patients with a blocked catheter who did not undergo an initial blood draw * Patient with known neurocognitive disorders incompatible with informed consent * Pregnant or breastfeeding woman * Patient under legal guardianship (guardianship or conservatorship) or patient deprived of liberty * Patient refusing to participate in the study * Patient participating in another interventional research study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for An initial order for A blood draw and placement of an iv line in the emergency department are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

An initial order for A blood draw and placement of an iv line in the emergency department

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AP HP Pitié Salpétrière

    Paris, 75 013, France

  • APHP Bichat

    Paris, 75 018, France

  • APHP CH Simone Veil

    Eaubonne, 95 600, France

  • APHP Henri Mondor

    Créteil, 94 010, France

  • APHP Lariboisière

    Paris, 75 010, France

  • APHP St Antoine

    Paris, 76 012, France

  • CHRU Nancy

    Nancy, 54 000, France

  • CHU Amiens

    Amiens, 80 000, France

  • CHU Angers

    Angers, 49 100, France

  • CHU Nantes

    Nantes, 44 093, France

  • CHU de ROUEN

    Rouen, 76 031, France

  • Ch Dieppe

    Dieppe, 76 202, France

  • Chu Clermont Ferrand

    Clermont-Ferrand, 63 000, France

  • Chu Toulouse

    Toulouse, 31 300, France

  • HCL Lyon Sud

    Lyon, 69 495, France

  • HIA Laveran Marseille

    Marseille, 13013, France